Heart Beat: Follow-up: Limit Natrecor to hospital use, say experts

Heart Beat

Follow-up: Limit Natrecor to hospital use, say experts

An independent panel of experts took a hard look at the safety of Natrecor (nesiritide), a controversial heart failure drug, and how it is used during the summer of 2005.

The panel, headed by Dr. Eugene Braunwald, a preeminent heart failure specialist and member of the Harvard Heart Letter editorial board, made these recommendations:

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »